PIEZO1 expression at the glio-vascular unit adjusts to neuroinflammation in seizure conditions.

Astrocytes Focal seizures IL1β Microglia NF-kB Neuro-inflammation Neuro-mechanobiology Pericytes Piezo1 TNFα

Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
15 Oct 2023
Historique:
received: 26 07 2023
revised: 12 09 2023
accepted: 13 09 2023
pubmed: 18 9 2023
medline: 18 9 2023
entrez: 17 9 2023
Statut: ppublish

Résumé

Mechanosensors are emerging players responding to hemodynamic and physical inputs. Their significance in the central nervous system remains relatively uncharted. Using human-derived brain specimens or cells and a pre-clinical model of mesio-temporal lobe epilepsy (MTLE), we examined how the mRNA levels of the mechanosensitive channel PIEZO1 adjust to disease-associated pro-inflammatory trajectories. In brain tissue micro-punches obtained from 18 drug-resistant MTLE patients, PIEZO1 expression positively correlated with pro-inflammatory biomarkers TNFα, IL-1β, and NF-kB in the epileptogenic hippocampus compared to the adjacent amygdala and temporal cortex tissues. In an experimental MTLE model, hippocampal Piezo1 and cytokine expression levels were increased post-status epilepticus (SE) and during epileptogenesis. Piezo1 expression positively correlated with Tnfα, Il1β, and Nf-kb in the hippocampal foci. Next, by combining RNAscope with immunohistochemistry, we identified Piezo1 in glio-vascular cells. Post-SE and during epileptogenesis, ameboid IBA1 microglia, hypertrophic GFAP astrocytes, and damaged NG2DsRed pericytes exhibited time-dependent patterns of increased Piezo1 expression. Digital droplet PCR analysis confirmed the Piezo1 trajectory in isolated hippocampal microvessels in the ipsi and contralateral hippocampi. The combined examinations performed in this model showed Piezo1 expression returning towards basal levels after the epileptogenesis-associated peak inflammation. From these associations, we next asked whether pro-inflammatory players directly regulate PIEZO1 expression. We used human-derived brain cells and confirmed that endothelium, astrocytes, and pericytes expressed PIEZO1. Exposure to human recombinant TNFα or IL1β upregulated NF-kB in all cells. Furthermore, TNFα induced PIEZO1 expression in a dose and time-dependent manner, primarily in astrocytes. This exploratory study describes a spatiotemporal dialogue between PIEZO1 brain cell-mechanobiology and neuro-inflammatory cell remodeling. The precise functional mechanisms regulating this interplay in disease conditions warrant further investigation.

Identifiants

pubmed: 37717661
pii: S0969-9961(23)00312-1
doi: 10.1016/j.nbd.2023.106297
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106297

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Valentin Garcia (V)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Marine Blaquiere (M)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Alicia Janvier (A)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Noemie Cresto (N)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Carla Lana (C)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Athenais Genin (A)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Helene Hirbec (H)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Etienne Audinat (E)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Adele Faucherre (A)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Emmanuel L Barbier (EL)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Grenoble Institute Neuroscience, U1216 Grenoble, France.

Sophie Hamelin (S)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Grenoble Institute Neuroscience, U1216 Grenoble, France.

Philippe Kahane (P)

Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Grenoble Institute Neuroscience, U1216 Grenoble, France.

Chris Jopling (C)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Nicola Marchi (N)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France. Electronic address: nicola.marchi@igf.cnrs.fr.

Classifications MeSH